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1. Introduction
The uses of plants as medication for various health condi-
tions are found in several countries of the world, including 
Nigeria.1 In the practice of alternative medicine, medicinal 
plants have been used for the management of numerous 
health conditions, and useful bioactive agents have been 
found present in various plant extracts, including essential 
oils. For example, Sesamum radiatum, a plant used to im-
prove fertility in male subjects, contains a yohimbine de-
rivative which has been suggested as the relevant bioactive 
agent.2 Cissus populnea is also used for the same purpose, 
and extracts from the stem have been found to promote ap-
preciable proliferation of Sertoli cells from rats.3 The essen-
tial oils from Euphorbia hirta and Calotropis procera, plants 
used in the management of asthma, have been found to be 
rich in phytol, an anti-inflammatory compound.4–6
Adenia cissampeloides (Planch. ex Hook.) Harms, com-
monly known as monkey rope or snake climber or Ade-
nia, belongs to the Passifloraceae family. It grows in tropical 
and subtropical regions. The acclaimed use of the plant in 
Nigeria is in the management of hypertension. It has also 
been found useful in the treatment of nervous disorders, 
leprosy, stress, cough, gonorrhoea, as well as antimicrobial 
treatment for wounds and sores.7 The roots, leaves, and 
stem-bark are usually employed as curative agents. The 
sap is also used as a facial cosmetic. A catalogue of vari-
ous uses of the plant worldwide contains additional me-
dicinal applications of the various plant parts, which are 
sometimes used singly or in combination with other parts 
of the plant. These include an infusion of the root, stem or 
leaves in treating various ailments, including headache and 
back pain. The roots in various preparations are used in the 
treatment of fever, malaria, scabies, cholera, anaemia and 
snake bites. They are also used as diuretic, abortifacient 
and arrow poison. Bees have been found to be passive 
when exposed to smoke from the burning roots. The roots 
in combination with the stem are administered to humans 
in order to expel intestinal worms. This mixture is also used 
for the management of venereal diseases and sterility. The 
leaves have been reported useful as an antipyretic and for 
the management of malaria, liver ailments, fractures, bron-
chitis, lung ailments, depression, and insanity. The bark has 
also been found useful in inducing amnesia and treating 
scabies. The stem has been employed as fish poison.8 The 
phytochemical constituents reported present in A. cis-
sampeloides include tannins, which have antibacterial and 
anti-inflammatory activity, saponins, phlobatannins, terpe-
noids, steroids, alkaloids, carbohydrates, glycosides, which 
may lower blood pressure, and flavonoids, which may ex-
hibit diuretic and antibacterial activity.9 Tetraphyllum B, a 
cyanogen glycoside, has been isolated from the roots of the 
plant.10 The aqueous extract of a herbal preparation ob-
tained from A. cissampeloides was administered to seven 
female patients in Ghana, and the systolic blood pressure 
was significantly lower in subjects on A. cissampeloides 
compared to control subjects not on the medication.11
Hypertension is a major health problem in black popu-
lations. The symptoms of hypertension include severe 
headaches, chest pain, breathing problems, irregular heart-
beats, and dizziness.12,13 Persistent hypertension is a risk 
factor for heart failure, stroke, and myocardial infarction, 
and is a major cause of chronic kidney failure.14 A single 
medication, sometimes combined with another, is often 
administered to hypertensive patients in order to maintain 
the blood pressure below 140/90. However, there are in-
cidences of resistant hypertension in which concurrent use 
of three anti-hypertensive medications of different classes 
do not keep the blood pressure below this value.15 This 
calls for further intensive search for anti-hypertensive med-
ications, possibly of plant origin.
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In this study, the isolation and GC-MS analyses of the es-
sential oils from the leaves of A. cissampeloides have been 
carried out primarily for identifying possible constituents 
that may reduce blood pressure, and other constituents 
that may be useful for the management of various health 
disorders for which A. cissampeloides is employed in al-
ternative medicine. The occurrences and bioactivities of 
several constituents and their current and potential appli-
cations in the pharmaceutical industry and medicine are 
discussed. Other possible applications of A. cissampeloides 
are suggested based on comparison of the constituents of 
the essential oils of the plant with those from other plants. 
2. Experimental
2.1. Plant procurement and processing
Fresh leaves of the Adenia cissampeloides (Planch. ex 
Hook.) Harms were obtained from vendors of medicinal 
plants in Mushin market in Lagos. The plant was identified 
by Mr. T. K. Odewo, formerly of the Department of Bot-
any of the Forestry Research Institute of Nigeria, Ibadan, 
where vouchers were deposited and assigned the number 
FHI 107683. The leaves were cut into small pieces and 
dried at room temperature in a dust-free environment in 
the laboratory, after which pulverization was carried out.
2.2 Isolation of essential oils
The essential oils were obtained by hydrodistillation using 
Clevenger apparatus. The procedure for isolation of the es-
sential oils has been described in a previous report.5 Two 
modes of collection were employed. In one mode, the es-
sential oil was collected hourly into hexane over a period 
of 4 h. In another mode, the essential oil was collected 
over a period of 4 h. The colour of the fractions in hexane 
increased in intensity from light orange for the first hour 
collection to deep orange for the 4th hour collection.
2.3 GC-MS analysis of the essential oils 
Analysis was carried on GC-MS model 7890A, Ag-
ilent Technologies, fitted with an HP-5MS column 
(30 m × 0.25 mm, 0.25 μm); carrier gas was helium at 
a flow rate of 1 ml min−1, and a temperature program 
50 °C (1 min) → 300 °C min−1 at 8 ° min−1 (5 min) was 
employed. Mass spectra were obtained on spectrometer 
model 5975 VLMSD. Identification of the compounds 
was carried out using the ChemStation software and the 
NIST 08 library in the instrument. The compound in the 
library with a minimum spectral match of 90 % compared 
with that of the constituent eluted from the GC was select-
ed as the corresponding compound. 
Fig. 1 – Chromatogram of the essential oil from the leaves of A. cissampeloides collected in 4 h
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3. Results and discussion
The chromatogram for the essential oil collected in 4 h is 
shown in Fig. 1, while constituents in all five essential oil 
samples are presented in Table l. The constituents include 
terpenes, oxygenated terpenes, alcohols, heterocyclic 
compounds, hydrocarbons, aldehydes, ketones, saturated 
and unsaturated fatty acids, and fatty acid methyl esters. 
Several of the constituents of the leaf essential oil of Ade-
nia cissampeloides (Planch. ex Hook.) Harms, such as az-
ulene, myrtenol, camphene, cubebene, α-humulene, fatty 
acids, alcohols, aldehydes, secondary ketones, phytol, and 
phenolics are typical compounds found in essential oils. 
The major constituent in the essential oil samples is phytol. 
Other constituents include α-linolenic acid, n-hexadeca-
noic acid, hexahydrofarnesyl acetone, (13S)-8,13-epoxy-
labd-14-ene, kaur-16-ene, guaiol, α-gurjunene and α-el-
emene. The major compound in the essential oil isolated 
in the 1st hour was germacrene D and 1,13-tridecanediol, 
diacetate in the 2nd hour. (13S)-8,13-epoxy-labd-14-ene 
and phytol were the major compounds in the 3rd hour , 
n-hexadecanoic acid and phytol in the 4th hour, and phytol 
in the sample collected over 4 h. The medicinal and phar-
maceutical applications of several of these constituents are 
here discussed. Essential oils from some plants were ob-
served to have several constituents in common with those 
isolated from A. cissampeloides. The bioactivities of such 
plants are used to suggest other possible applications of A. 
cissampeloides.
Table 1 – Constituents of the essential oils from the leaves of A. cissampeloides
S/No RT ⁄ min Compound Percentage of total
1st h 2nd h 3rd h 4th h 4 h
1. 6.40 tSabinene – – – – 0.2
2. 6.70 1-ethyl-3-methylbenzene – – – – 0.2
3. 8.77 otβ-Linalool 1.1 – – – –
4. 10.21 otTerpinen-4-ol – – – – 0.4
5. 10.35 Azulene 1.9 1.3 – – 3.8
6. 10.53 otα-Terpineol 1.0 – – – –
7. 10.64 ot(−)-Myrtenol 2.3 – – – –
8. 12.27 Indole – – – 0.4 –
9. 12.97 tγ-Elemene – – – – 0.9
10. 13.03 2,5,5-Trimethyl-1,3,6-heptatriene – 1.5 – – –
11. 13.08 tCamphene 3.7 – – – –
12. 13.32 o-Eugenol – 0.6 0.3 0.8 –
13. 13.72 tα-Cubebene 1.9 – – – 0.5
14. 13.95 tβ-Elemene 3.9 1.7 – – –
15. 14.39 tCaryophyllene – – – – 2.2
16. 14.50 t4,8,8-Trimethyl-2-methylene-4-vinylbicyclo[5.2.0]nonane, 2.4 – 0.5 –
17. 14.62 t2-Isopropyl-5-methyl-9-methylene-bicyclo[4.4.0]dec-1-ene 1.2 – – – 1.7
18. 14.69 tAlloaromadendrene – – – – 0.2
19. 14.94 Geranylacetone 1.5 – – – 0.5
20. 15.00 2,6-Diaminopyridine – – 2.3 – –
21. 15.04 tα-Humulene 2.8 – – – –
22. 15.04 tβ-Gurjunene – – – – 0.2
23. 15.25 tα-Amorphene – – – – 0.6
24. 15.32 tγ-Muurolene – 0.6 – – –
25. 15.40 tβ-Cubebene – – – 1.1 –
26. 15.44 tGermacrene D 11 6.5 – – –
27. 15.54 β-Ionone – – – – 2.3
28. 15.68 tBicyclogermacrene 3.6 3.8 – – –
29. 15.70 tδ-Guaiene – – – – 0.3
30. 16.08 tδ-Cadinene 2.3 1.4 0.5 0.6 1.1
31 16.41 otElemol – – 2.1 1.1 2.8
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S/No RT ⁄ min Compound Percentage of total
1st h 2nd h 3rd h 4th h 4 h
32. 16.89 ot(−)-Spathulenol – – – 1.3 –
33. 16.99 otCaryophyllene oxide – – 0.4 – 1.1
34. 17.16 ot(+)-Spathulenol 3.4 4.7 1.4 – 2.7
35. 17.16 otGuaiol 2.6 1.4 0.5 – –
36. 17.22 1,12-Dodecanediol – – – 0.6 –
37. 17.23 trans-2-Dodecen-1-ol – – 0.9 – 0.8
38. 17.67 otγ-Eudesmol – – 0.5 – –
39. 17.95 otβ-Eudesmol – – – 0.9 –
40. 18.02 tγ-Gurjunene – – 4.9 – 3.4
41. 18.04 tα-Gurjunene 1.8 7.2 – – –
42. 18.12 Cyclotetradecane – – – 0.3 –
43 18.14 tα-Elemene 6.3 2.5 –
44. 18.14 Cyclodecane – – 1.0 – –
45. 18.53 Tetradecanal 5.1 – 1.6 – –
46. 18.65 Pentadecanal – – – – 6.9
47. 18.71 (E)-2-Tridecen-1-ol – – – 6.5 –
48. 18.73 11-Tetradecyn-1-ol-acetate – – 5.9 – –
49. 18.76 1,13-Tridecanediol diacetate - 7.9 – – –
50. 19.46 1-Hexadecanol 0.7
51. 19.51 Benzyl Benzoate 0.6 0.7 0.7 0.5 0.6
52. 19.52 1,13-Tetradecadiene – – – 1.5 –
53. 19.73 cis,cis,cis-7,10,13-Hexadecatrienal – – 1.0 – –
54. 20.01 18-Nonadecen-1-ol – – 0.5 – –
55. 20.47 Hexahydrofarnesyl acetone 2.1 4.4 5.1 5.0 4.8
56. 20.51 (Z)6, (Z)9-Pentadecadien-1-ol – – 0.3 – –
57. 20.71 faPentadecanoic acid – – 0.8 – –
58. 20.86 1,4-Ecosadiene – – 0.8 – –
59. 20.99 cis,cis-7,10-Hexadecadienal – – – 5.3 –
60. 21.12 usfaα-Linolenic acid – – 5.6 6.8 –
61. 21.61 ot3,5,11,15-tetramethyl hexadec-1-en-3-ol- – – – – 1.0
62. 21.70 otIsophytol – – 2.3 – –
63. 21.93 fan-Hexadecanoic acid – 0.5 0.7 8.9 3.1
64. 22.48 tKaur-15-ene – – 0.2 – –
65. 22.76 (13S)-8,13-epoxy-labd-14-ene – 6.4 7.2 6.9 2.4
66. 22.98 tKaurene – – – – 0.8
67. 23.08 tKaur-16-ene 1.7 2.2 2.6 2.3 –
68. 23.41 fameLinoleic acid methyl ester 0.7
69. 23.41 usfaLinoleic acid – – – 0.7 –
70. 23.48 fameOleic acid, methyl ester – – 1.1 1.6 –
71. 23.70 otPhytol 2.8 7.6 7.2 8.9 19.7
72. 23.89 usfaLinoleic acid – – – 0.4 –
73. 23.89 usfaOleic acid 1.7
74. 23.93 [(2,4,6-Triethylbenzoyl)thio]-acetic acid – – 1.4 –
Table 1 – (continued)
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S/No RT ⁄ min Compound Percentage of total
1st h 2nd h 3rd h 4th h 4 h
75. 24.22 faOctadecanoic acid – – 1.2 0.9 –
76. 25.30 otKauran-16-ol – 1.1 – – 0.3
77. 25.33 ot16.β.H-Kauran-16-ol – – 2.4 – –
78. 25.50 1,2-Benzisothiazole,3-(hexahydro-1H-azepin-1-yl)-,1,1-dioxide – – – – 0.8
79. 27.62 1-Iodooctadecane – – 0.3 – 0.1
80. 31.17 9-Butyldocosane – – – – 0.2
Total 67.8 63.9 64.4 67.0 66.3
Key: t = terpene, ot = oxygenated terpene, fa = fatty acid, usfa = unsaturated fatty acid, fame = fatty acid methyl ester.
Sabinene is a monoterpene and is the subject of several 
patents. Monoterpenes have been found to exhibit sev-
eral pharmacological properties, including antifungal, 
antibacterial, antioxidant, anticancer, and antispasmodic 
activities.16 This constituent, when incorporated in some 
compounds, has been found to have great medicinal po-
tentials. When it occurs in natural compounds, its possible 
roles can thus be considered. For example, it is useful in 
the enhancement of activity of antibiotics. Oxazolidinone 
antibiotics are known to be active against multi-drug resist-
ant Gram-positive organisms. They are not cross-resistant 
with other antibiotics.17–18 In an invention, oxazolidinones 
having a bicyclic[3.1.0] hexane-containing moiety were 
found to be effective against aerobic, anaerobic pathogens 
including multi-resistant staphylococci, streptococci, and 
enterococci, bacteroides species, clostridia species as well 
as acid–fast organisms, such as Mycobacterium tuberculo-
sis and other mycobacterium species which are implicated 
in leprosy.19 A study based on the work of Basile et al.20 
and Skolnick et al.21 provides novel 1-heteroaryl-3-azab-
icyclo[3.1.0] hexanes and similar processes and interme-
diates for synthesizing such compounds and compositions 
and methods using the compounds for the treatment or 
prevention of central nervous system (CNS) disorders, in-
cluding depression and anxiety. Some experiments22 based 
on studies carried out by P. Skolnick et al.23 and M. Briley24 
showed that phenyl substituted-3-azabicyclo[3.1.0] hex-
anes inhibited the reuptake of biogenic amines that serve 
as neurotransmitters in the CNS. Therefore, compounds 
which inhibit the reuptake of these neurotransmitters 
may be useful as antipsychotic agents, effective in treating 
CNS disorders, including drug dependency. Bicyclic com-
pounds have also been reported to be nicotinic acetylcho-
line receptor inhibitors, and have been found useful for the 
treatment of clinical conditions, such as anxiety, Alzheimer 
disease, depression, convulsive disorders, cognitive mem-
ory disorders, Attention Deficient Disorder/Hyperactivity 
Syndrome, inflammation, pain, psychosis, mania, Parkin-
son’s disease, sleep disorders, and disorders of the CNS 
related to or affected by certain nicotinic receptors.25–29 
These bicyclic [3.1.0] hexane-containing moiety and de-
rivatives have not been reported present in any extract of 
A. cissampeloides, but the presence of this constituent in 
the essential oil suggests the potential of the plant for the 
management of nervous disorder, stress, venereal diseases, 
and leprosy.7,8
β-Linalool is a terpene alcohol. In a review article, it was 
reported that monoterpenes have been found to exhibit 
significant effects on the cardiovascular system30 in addi-
tion to those listed previously.16 In a study on the effect of 
the optical isomers of linalool on human subjects, it was 
observed that while (+)-linalool exhibited stimulating ef-
fect on the cardiovascular system, (−)-linalool exhibited a 
depressing effect.31 Linalool is usually found in the racemic 
form in nature. (±)-Linalool has been reported to induce 
hypotension associated with tachycardia in rats.32 Thus, 
this constituent may cause the reduced systolic blood pres-
sure observed in hypertensive human subjects who were 
treated with herbal preparations of the plant.11 Several pat-
ents have been filed on the various applications of linalool. 
One of such is on the control of ticks and fleas with linal-
ool.33 The patent is based on a report on the inhibition of 
houseflies by certain terpenoids.34 Thus, A. cissampeloides 
may function as a broad-based insecticide not limited to 
scabies. This constituent is also present as the major vol-
atile constituent (15.6 %), of Thea viridis, green tea,35 and 
in the essential oil of the oleo-gum resin of Frankincense, 
Boswellia species (6.64 %), which has been identified for 
its immune-enhancing, antibacterial, antifungal, antiviral, 
antiseptic, wound healing, anti-inflammatory, and an-
ti-cancer properties.36 Some of these bioactivities may be 
exhibited by A. cissampeloides.
F. Mondello et al.37 established the efficacy of terpinen-4-ol, 
the main component (30 % minimum) of Melaleuca al-
ternifolia Cheel (tea tree oil), against human pathogenic 
Candida species which were azole-susceptible and -resist-
ant. The susceptibility of Legionella pneumophila, one of 
the microorganisms implicated in Legionnaire’s disease, 
to M. alternifolia oil, was also reported.38 These studies37,38 
formed the basis of a patent39 which refers to the use of 
terpinen-4-ol, both aqueous solution and vapour forms as 
antimicrobial agent against bacteria of Legionella genus, 
preferably L. pneumophila for disinfecting systems for the 
distribution of water in various facilities. Terpinen-4-ol is 
reported to be the major constituent of the essential oil 
from Alpinia zerumbet or Alpinia speciosa (Blume) D. Dietr, 
which is widely used as a tea in the management of arterial 
hypertension in alternative medicine.30 S. Lahlou et al.40,41 
reported the cardiovascular and antihypertensive effects of 
terpinen-4-ol, and concluded that the hypotensive effects 
of the essential oil are partially attributed to the actions of 
terpinen-4-ol. Thus, this constituent has antihypertensive 
Table 1 – (continued)
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activity and may contribute to the observed antihyperten-
sive activity of A. cissampeloides.11
Azulene has been recognized for its soothing effect, anti-in-
flammatory activity, and several medicinal applications. Its 
anti-inflammatory activity has been demonstrated in sever-
al animal models.42 A derivative, chamazulene carboxylic 
acid, is a natural profen with anti-inflammatory activity.43
α-Terpineol is irritating to eyes, respiratory system, and skin. 
It constitutes 0.3 % of the essential oil sample collected 
over a period of four hours. α-Terpineol has been report-
ed to exhibit a hypotensive effect in rats and also induce 
vasorelaxation.44,45 These two effects have been confirmed 
and possible pathways proposed for the effects.46 α-Terpi-
neol has been reported to exhibit antioxidant, antiseptic, 
anti-hypernociceptive and anti-inflammatory activity47,48, 
and may confer some of these bioactivities on the plant 
essential oil. 
(−)-Myrtenol, a bicyclic monoterpene alcohol, has been 
reported to exhibit hypotensive effects at doses of l mg kg−1 
when administered intravenously in rats.44 It may function 
in a similar manner in human subjects.
Indole is a precursor to many pharmaceutical products, 
and the indole core is commonly found in several varie-
ties of biologically active compounds.49 Indole structures 
are able to bind many receptors in the body and hence 
are considered privileged structure motifs.50 Thus, a great 
deal of research has been dedicated to incorporate indole 
in the synthesis of new anti-mitotic compounds for the 
treatment of cancer. One of such compounds, 5-meth-
oxy-1-(3,4,5-trimethylphenyl)-1-H-indole, is described as 
having possible anti-mitotic properties.51 Aromatic ethers 
derived from indole have been synthesized and found 
useful for the treatment of diseases linked to the dysfunc-
tion of 5HT1-like receptors.52 5-hydroxytryptamine (5HT), 
commonly called serotonin, is proposed to play an impor-
tant role in various pathological conditions, such as psy-
chiatric disorders, including anxiety, depression, aggres-
siveness, panic attacks, obsessive compulsive disorders, 
schizophrenia, suicidal tendency, and some neurodegen-
erative disorders, including Alzheimer’s disease, Parkin-
sonism, as well as other health disorders, such as migraine, 
cephalalgia and those linked to alcoholism.53–58 Most of the 
compounds synthesized are potent agonists of 5HT1-like 
receptors, and are used for the treatment of migraine and 
vasospatic disorders.59–64 3,5-Substituted indole has been 
found useful in the control of visceral pain which may be 
caused by disease or injury to some internal organs. Exam-
ples of visceral pains managed by such compounds include 
inflammatory bowel syndrome, pancreatitis, diverticulitis, 
Crohn’s disease, peritonitis, gastroenteritis, endometriosis, 
dysmenorrheal interstitial cystitis, dyspepsia, renal colic or 
biliary colic.65 These indole derivatives have not been re-
ported present in any extract of A. cissampeloides, but the 
occurrence of indole in the essential oil may contribute to 
the use of the plant isolate for the management of nervous 
disorders in alternative medicine.7
γ-Elemene has been reported present in appreciable quan-
tity in the leaf essential oil samples of Murraya microphylla 
and Murraya alata. Caryophyllene, present in the essential 
oil from A. cissampeloides, is also present in the essential 
oil of M. microphylla. The essential oil from the two Mu-
raya species have been shown to exhibit antibacterial and 
antioxidant properties.66 Thus, γ-elemene and caryophl-
lene may contribute to the antibacterial activity of herbal 
preparations from A. cissampeloides.7 
2,5,5-Trimethyl-1,3,6-hepatriene is an alkene, and has 
been reported to be a constituent of the essential oil of 
Salvia bertolonii Vis and Salvia pratensis L. S. pratensis is 
used as a bactericidal agent for ulcers, wound healing, sore 
throat, and influenza.67
Camphene, a bicyclic monoterpene, is a constituent of 
many plant essential oils. It is non-toxic and is used as food 
additive, for artificial flavouring, and in fragrances, as well 
as in the manufacture of synthetic camphor and insecti-
cides. It has been found to reduce plasma cholesterol and 
triglycerides in hyperlipidemic rats.68 Accumulation of li-
pids, plasma cholesterol and triglycerides within the blood 
vessels of the artery is central to the development of ath-
erosclerosis and coronary heart disease 69–71. In a study, it 
was found that lipid-lowering therapy is effective in reduc-
ing cardiovascular mortality and morbidity in people with 
peripheral arterial disease, and statin is the recommended 
drug.72 However, some patients do not tolerate statin, while 
for some, using statin treatment alone does not achieve 
the desirable lipid level. Thus, there is need to investigate 
other possible compounds, including those of plant origin, 
with the same cholesterol-lowering effect.68 The hypolipi-
demic property of the essential oil from Chios mastic gum, 
MGO, a resin produced by the plant Pistacia lentiscus var. 
Chia,73 was evaluated in rats in which hyperlipidemia was 
detergent-induced. Treatment of HepG←2 cells with cam-
phene led to a decrease in cellular cholesterol content to 
the same level as mevinolin, a potential lipid-lowering drug 
and a well-established 3-hydroxy-3-methylglutaryl coen-
zyme A (HMG-CoA) reductase inhibitor. The hypolipi-
demic activity of MGO was unequivocally attributed to 
camphene, a minor constituent (0.8 %) of the essential oil. 
However, synergistic action between camphene and other 
MGO components was observed. Camphene did not ex-
hibit cytotoxicity in human hepatic cells and may be devel-
oped as an alternative lipid-lowering agent.68 In a study on 
some plant-derived antioxidants, geraniol and camphene 
were found to offer significant protection against reactive 
oxidation species. The results from the study indicated the 
pharmacological potential of the two compounds in the 
management of lung inflammatory diseases which arise 
from oxidative stress.74 Camphene (3.7 %) was found pres-
ent in the 1st hour essential oil fraction of A. cissampeloi-
des, and may contribute to the observed antihypertensive 
action of the plant extract in clinical trials11 as well as to its 
use in the management of bronchitis and lung ailments in 
alternative medicine.8
o-Eugenol is one of the terpenoid compounds found to ex-
hibit muscle relaxant, anaesthetic and inhibitory effect on 
locomotion. Methyl eugenol and cineol also exhibited sim-
ilar effects.75 The sedative effects and motor impairment 
activity of the root extract of Ferula gummosa have been 
proposed to be caused by these terpenoid compounds.76 
Thus, o-eugenol may be responsible for the use of A. cis-
sampeloides in the management of stress and nervous dis-
orders.7
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α-Cubebene is one of the sesquiterpenes derived from the 
fruit of the Osage tree, Maclura pomifera. In some studies, 
the constituent sesquiterpenes, singly or in combination, 
were reported to exhibit excellent repellency against ar-
thropods, such as cockroaches, mosquitoes, mites, ticks, 
and spiders.77 Several of these constituents performed bet-
ter than the commercial standard N,N-diethyl-3-methylb-
enzamide (DEET) against female German cockroaches and 
are contained in a patent. These reports are the basis of 
a patent on repellents obtained from terpenoids for use 
against arthropods.78 These repellents are less toxic than 
N,N-diethyl-1,3-methylbenzamide, (DEET), which has 
been reported to cause severe adverse health effects.79,80 
α-Cubebene may thus increase the insecticidal activity of 
A. cissampeloides.8 This constituent has also been found to 
be the major constituent in the volatile oil from the peel 
and flesh of Garcinia mangostana, L. with relative contents 
of 32 % and 41 %, respectively,81 and an extract of the 
plant has been found to offer protective effects against in-
duced cytotoxic changes and increased level of reactive 
oxygen species, and it has been suggested that the extract 
may prevent or decrease the severity of Alzheimer dis-
ease.82 It is possible that α-cubebene may contribute to 
the effectiveness of A. cissampeloides in the management 
of nervous disorders in alternative medicine and may also 
enhance the insecticidal activity of the plant.8
β-Elemene is present in the 1st and 2nd hour fractions. It 
is a constituent of Piper nigrum which has been found to 
exhibit insecticidal activity, and is also employed in alterna-
tive medicine in the management of haemorrhoids, cold, 
congestion, dyspepsia, vomiting, and diarrhea.83
Caryophyllene, also known as β-caryophyllene, is a bicyclic 
sesquiterpene present in essential oils of many plants and 
has several medicinal properties. These include anti-in-
flammatory, anti-carcinogenic, antioxidant, antimicrobial, 
and analgesic properties.84 In a study, β-caryophyllene was 
found to increase paclitaxel activity by ten-fold, thus poten-
tiating the anti-cancer activity of paclitaxel on some human 
tumour lines, suggesting that β-caryophyllene facilitates the 
passage of paclitaxel through the cell membrane.85 Caryo-
phyllene is present in appreciable quantities in Cannabis 
sativa (3.8–37.5 %). A cannabis extract, sativex, is used in 
Canada for the treatment of neuropathic pain in multiple 
sclerosis, and because (E)-β-caryophyllene is a significant 
constituent in cannabis essential oil and shows significant 
cannabimimetic effects, it is proposed that it may contrib-
ute to the overall effect of cannabis medications. Caryo-
phyllene has thus been declared to potentially modulate 
inflammatory and other pathophysiological processes.86 
It is also a constituent of essential oils (51.8–57.6 %) ob-
tained from the dried fruits of Piper guineense87 common-
ly used for the management of mental illness, impotence, 
hypertension, and as antimicrobial in the practice of alter-
native medicine in Nigeria88, and was also found to exhib-
it hepatoprotective effect.89 Caryophyllene has also been 
demonstrated to be potentially useful in the prevention 
and treatment of colitis.90 In a study on the anti-tumour 
properties of the volatile oil from Zanthoxylum rhoifolium 
Lam leaves and some terpenes including β-caryophyllene 
in vitro and in vivo, it was concluded that the volatile oil 
exhibited efficient anti-tumour activity and significant im-
munomodulatory action in vivo, which may be attributed 
to β-caryophyllene associated to the synergism of other 
natural compounds present in the volatile oil.91 The listed 
bioactivities of β-caryophellene may also be expected to 
be present in preparations of A. cissampeloides. 
Caryophyllene oxide has been reported to be anti-inflam-
matory as well as acting as peripheral analgesic, and ex-
hibiting activity against C. albicans and repellence against 
Anopheles gambiae, a malaria vector.92 It has also been 
proposed as a potential therapeutic compound for the 
prevention and treatment of cancer.93 It has been found to 
exhibit sedative effect on silver catfish.94 Studies on Sature-
ja parnassica oil, which is very rich in caryophyllene oxide, 
has been found to show moderate antibacterial activity 
against Helicobacter pylori.95 Thus, caryophyllene oxide 
may contribute to the bioactivity of A. cissampeloides as an 
antimicrobial and an analgesic for headache and back pain 
as claimed in alternative medicine.8
4,8,8-Trimethyl-2-methylene-4-vinylbicyclo[5.2.0]nonane 
has been found to be a constituent (12 %) of the vola-
tile oils from Fusarium trincinctum, an endophytic fungus 
which showed antimicrobial activity against eight bacteria 
and two fungi.96 
2-Isopropyl-5-methyl-9-methylene-bicyclo[4.4.0]dec-1-
ene is reported present in the essential oil from chocolate 
mint (2.75 %), which was observed to possess scavenging 
NO radical activity as well as anti-inflammatory activity.97 
Alloaromadendrene and caryophyllene, both present in 
the essential oils from A. cissampeloides have been found 
present in the essential oil from the leaves of Psidium gua-
java,98 which have been reported to exhibit antibacterial 
property and were efficacious in the management of diar-
rhea, dysentery, and gastroenteritis.99
Geranyl acetone has been reported present in the leaf es-
sential oil obtained from S. radiatum, a pro-fertility medici-
nal plant2, and also in the rhizome of two types of Curcuma 
longa grown in Bangladesh and used in the management 
of jaundice, liver ailments, ulcers, parasitic infections, and 
skin diseases.100 The compound has also been reported as 
a constituent of volatile organic compounds in normal skin 
area in a study on analytical profiling of chronic wounds.101 
α-Humulene has been isolated from the essential oil of 
Cordia verbenacea and was found to produce anti-inflam-
matory effects comparable to those observed in dexameth-
asone-treated animals.102 This constituent may be useful in 
the management of pain arising from inflammation, and 
may be responsible for this bioactivity of A. cissampeloides. 
α-Amorphene, a sesquiterpene, and some other constitu-
ents in the essential oil from A. cissampeloides, including 
α-terpineol, camphene, β-elemene, caryophyllene, α-hu-
mulene, γ-muurolene, δ-cadinene (−)-spathulenol, and 
caryophyllene oxide have been reported present in the 
flower essential oil of Magnolia liliflora, which has been 
found effective in the management of decubitus ulcer in 
nursing pregnant women.103 It is possible that the leaf es-
sential oil from A. cissampeloides may exhibit such bio-
activity. This finding is relevant to the use of preparations 
from A. cissampeloides in the treatment of wounds and 
sores. 
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γ-Muurolene, a sesquiterpene, and other constituents, 
namely, terpinen-4-ol, β-elemene, α-amorphene, δ-ca-
dinene, and n-hexadecanoic acid, all present in the essen-
tial oil from A. cissampeloides, have been reported present 
in the essential oil obtained from Radix Linderae, which has 
been found useful in preventing the occurrence of decubi-
tus in aged people.104 This observation may lead to the ex-
pectation that A. cissampeloides and R. Linderae essential 
oils may have some bioactivities in common.
Germacrene D, an anti-mosquito compound,105 has been 
found present in the ethanol extracts of the leaves of Vitex 
negundo L. Other compounds present in the extract, which 
are also present in the essential oils from A. cissampeloides, 
include β-elemene, caryophyllene oxide, (+)-spathulenol, 
α-linolenic acid, n-hexadecanoic acid, phytol, and octade-
canoic acid. The ethanol leaf extract of V. negundo was ob-
served to possess remarkable larvicidal, oviposition deter-
rent and repellent activity against hazardous mosquitoes, 
namely Aedes aegypti, Anopheles stephensi, and Culex 
quinquefasciatus.106 Thus, some bioactivities, especially 
repellence activity may be observed in A. cissampeloides.
β-Ionone is a constituent of a formulation for exterminat-
ing lice and lice eggs. The formulation consists of one or 
more terpenes, namely, limonene, β-ionone, linalool, ge-
raniol, myrcene, and carvone. β-Ionone has antibacterial 
and antifungal properties.107 Thus, the essential oil form A. 
cissampeloides may be expected to exhibit antimicrobial 
activity as well as these insecticidal properties.
Bicyclogermacrene has been reported present in the es-
sential oil from the fresh leaves of Piper cernuum and Pip-
er regnellii. Other constituents present in both P. regnellii 
and essential oils from the leaves of A. cissampeloides in-
clude linalool, α-terpineol, β-caryophyllene, α-humulene, 
spathulenol, and caryophyllene oxide. The essential oils 
obtained from P. cernuum and P. regnellii were observed to 
display significant activities against Staphylococcus aureus 
and Candida albicans.108 This antimicrobial activity may be 
expected to be observed in the essential oils from A. cis-
sampeloides. 
δ-Cadinene is present in all the fractions. It has been iden-
tified as one of the major components in the essential oil 
from the peel of orange fruit, Citrus sinensis. The essential 
oil of C. sinensis exhibited antimicrobial activity against 
some Gram-positive and Gram-negative bacteria as well as 
Candida strains.109
(+)- and (−)-spathulenol, β-caryophyllene, and caryophyl-
lene oxide, all present in the essential oils of A. cissampe-
loides, have also been reported present in the leaf essential 
oil of Stevia rebaudiana, and these constituents have been 
demonstrated to partially account for the antimicrobial ac-
tivity of the aqueous leaf extract of S. rebaudiana.110 Ex-
tracts from the plant have been found to act as a hypoten-
sive regulator and also observed to possess hypoglycemic, 
antimicrobial, and contraceptive activities. Caryophyllene 
oxide and spathulenol constituted 43 % of essential oil 
from leaves of S. rebaudiana from Brazil.111 These two con-
stituents identified in Salvia sclarea oil were found to be 
active against S. aureus.112 The essential oil obtained from 
Salvia elegans Vahl, was found to contain spathulenol and 
caryophyllene as the major components, and was reported 
to exhibit excellent inhibitory larvicidal effect against Ae-
des albopictus, a mosquito vector.113 This bioactivity may 
be exhibited by A. cissampeloides.
(+)-Spathulenol, (−)-guaiol, and caryophyllene oxide 
were the isolated compounds from the essential oil of 
Aloysia gratissima responsible for anaesthetic induction 
in silver catfish. Spathulenol showed potent sedative and 
anaesthetic activities in silver catfish, and was proposed as 
a viable compound for the development of a new anaes-
thetic.94 
Guaiol has been found present in the essential oil of Teu-
crium polium L. and was reported to inhibit the intestinal 
motility of the isolated rabbit jejunum. Crystalline isolation 
and physicochemical characterization has identified guaiol 
as a major constituent of an active spasmolytic fraction of 
the essential oil of T. polium L.114 Guaiol was found to ex-
hibit sedative effect on silver catfish.94 Thus, the essential 
oil from A. cissampeloides leaves may exhibit anaesthetic 
effect. 
α-Gurjunene and elemol both present in the essential oil 
from A. cissampeloides have been found present in the vol-
atile components in Rhizome Zingibers, Zingiber Officinale 
Roscoe, and Ginger Pee which are used in Chinese tradi-
tional medicine for rheumatism, cold, stomach pain, and 
diarrhea.115
Benzyl benzoate emulsion was reported in 1946 as a very 
effective miticide in the management of scabies, and when 
incorporated at 68 % v/v into a mixture of dichlorodiphe-
nyltrichloroethane, DDT (6 %), benzocaine (12 %), and 
Tween 80 (14 %), was found to be miticidal, larvicidal, lou-
sicidal, ovicidal and antipruritic. DDT is ineffective against 
human scabies.116 This constituent may contribute to the 
effectiveness of the leaves of A. cissampeloides in the man-
agement of scabies. 
Cis,cis,cis-7,10,13-Hexadecatrienal is one of the major 
constituents in the methanol leaf extract of Lantana ca-
mara, which was found to have larvicidal effect on some 
species of mosquitoes. Other constituents present in the 
extract, which are also found in the essential oils from A. 
cissampeloides, include oleic acid, hexadecanoic acid, and 
phytol.117 n-Hexadecanoic acid, present in the essential 
oils from both plants, has been reported as a potent mos-
quito larvicide.118 Thus, the essential oils from the leaves 
of A. cissampeloides may function as a mosquito larvicide.
Hexahydrofarnesyl acetone is present in all the hourly 
fractions as well the 4-hour sample. It has been report-
ed present in appreciable concentration in the essential 
oil obtained from the leaves of C. procera (Ait.) R. Br. The 
insecticidal potential and possible role in malaria control 
was discussed.5 It is the oxidation product of phytol119 and 
some of this constituent may actually be present as phytol 
in the native plant material prior to hydrodistillation.
Cis,cis-7,10-Hexadecadienal has been reported present as 
one of the major constituents in the essential oil obtained 
from the leaves and stem of Euphorbia heterophylla, a me-
dicinal plant used traditionally in the management of gon-
orrhoea, respiratory tract infection, and warts, and found 
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effective as a fish poison and insecticide. It has also been 
shown to exhibit some antimicrobial and anti-inflamma-
tory properties. Other constituents common to the essen-
tial oils of E. heterophylla and A. cissampeloides include 
linoleic acid, phytol, oleic acid, and octadecanoic acid.120
Isophytol has been reported to be very toxic to aquatic life 
with very long lasting effects, and is suspected of damaging 
fertility or human foetus. It is also reported to irritate the 
eyes, skin, and respiratory system.121 Isophytol in the es-
sential oil may be an abortifacient.
Phytol has been found present in some medicinal plants 
used in the management of asthma in alternative medicine. 
These include essential oils from the leaves of C. procera5 
and E. hirta.4 The anti-inflammatory property of phytol as 
well as its reactive oxygen species-promoting property and 
its bioactivity in long suppression of arthritis6 was suggested 
as being responsible for the possible response of asthmat-
ic patients when these extracts are employed in alterna-
tive medicine. The appreciable quantity of phytol in the 
essential oil of A. cissampeloides may be suggestive of a 
possible role of the plant in the effective management of 
arthritis and asthma. Phytol has been identified as a major 
component in the ethyl acetate-soluble fraction obtained 
from the methanolic extract of the leaves of Pereskia bleo, 
a medicinal plant alleged to have anti-cancer, anti-tumour, 
anti-rheumatic, anti-ulcer, and anti-inflammatory proper-
ties. It is also used for the relief of gastric pain. In a study 
of the cytotoxic activity of the plant122, it was found that 
the ethyl acetate fraction exhibited high cytotoxic activity 
against human nasopharyngeal epidermoid carcinoma cell 
line and lower toxicity against human colon carcinoma cell 
line and hormone-dependent breast carcinoma cell line. 
It was proposed by the authors that phyto1, which has 
been found to show significant anti-tumour activity against 
mouse lymphocytes leukaemia cells, lymphoid leukaemia 
cells, human colon cancer cells, and gastric cancer cells, 
was responsible for the reported bioactivity of the plant. 
This suggests that the essential oils from A. cissampeloides 
may exhibit some anti-cancer and anti-tumour activity due 
to the presence of phytol. Phytol has also been reported to 
be a tumour promoter on l CR mouse skin.123 Phytol and 
derivatives are the subject of a patent claiming that these 
compounds can serve as active ingredients in medicaments 
to lower serum levels of triglycerides and/or cholesterol, 
and can be administered to patients with disease condi-
tions, such as type II diabetes, obesity or patients with car-
diovascular disease.124 These findings may also explain the 
anti-hypertensive activity of A. cissampeloides, and suggest 
the usefulness of the plant in the management of type II 
diabetes and obesity.
The essential oils contain five kaurene derivatives, namely, 
kaurene-15-ene, kaurene-16-ene, kaurene, kauran-16-ol, 
and 16 .β. H-kauran-16-ol. Kaurane diterpenes, including 
(−)-ent-kaur-16-en-19-oic acid, (−)-kaur-16-en-19-ol, 
and (−)-kauran-16-α-o1, have been reported to be effec-
tive against trypomestigotes of Trypanosome cruzi, a para-
sitic protozoan capable of causing life-threatening infec-
tions and cardiac complications.125 Natural stevioside has a 
kaurene skeleton as aglycone. It has been shown that it can 
lower blood sugar126 and blood pressure.127 In animal stud-
ies, it has been shown to be a diuretic and was also found 
to stimulate the secretion of insulin.128 Medicaments in-
corporating kaurene structure have been patented for the 
treatment of non-insulin dependent diabetes mellitus and 
hypertension129, and also for treating and preventing cor-
onary heart disease, cerebral apoplexy, cerebral ischemia, 
and rhythm disturbance.130 These reports suggest possible 
medicinal applications of A. cissampeloides.
The saturated fatty acids in the essential oils are pentade-
canoic acid, n-hexadecanoic acid, and octadecanoic acid, 
while the unsaturated fatty acids are α-linolenic acid, lin-
oleic acid, and oleic acid. n-Hexadecanoic acid and α-lino-
lenic acid are present in appreciable quantities compared 
to the other fatty acids. Fatty acids are reported to exhibit 
antibacterial and antifungal properties.131,132 n-Hexadeca-
noic acid inhibits phospholipase A2 which hydrolyses ester 
bonds and initiates steps resulting in inflammation which 
can lead to pathological conditions of rheumatoid arthritis, 
bronchial asthma, ulcerative colitis, psoriasis, and Crohn’s 
disease.133 The anti-inflammatory property of n-hexadeca-
noic acid, including structural evidence and kinetic meas-
urements, has been reported133 and the authors proposed 
that the results validate the rigorous use of oils rich in hex-
adecanoic acid for the treatment of rheumatic systems. 
This fatty acid is also reported to be hypocholesterolemic, 
nematicidal, pesticidal, and functions as an antioxidant, 
anti-androgenic flavour and 5-α-reductase inhibitor134 and 
a potent mosquito larvicide.118 Octadecanoic acid exhibits 
antimicrobial activity.118 Linoleic acid methyl ester exhib-
its anti-cancer activity.135 Oleic acid exhibits antibacterial 
activity136, while α-linolenic acid exhibits higher anti-in-
flammatory activity than docosahexaenoic acid.137 The 
occurrence of these fatty acids in the essential oils from 
A. cissampeloides may render the plant effective in the 
management of diseases which arise from inflammation; 
these include bronchial asthma and arthritis. These fatty 
acids also support the antimicrobial activity of the plant, 
and suggest its potential as anti-cancer agent and mosquito 
larvicide. 
Analysis of the hourly fractions of the essential oils revealed 
the occurrence of some constituents that were not detect-
ed in the conventional 4-hour collection. These results are 
a guide to the fractions that are rich in certain constitu-
ents. For example, azulene, caryophellene, and phytol are 
found largely in the 4-hour collection, while (−)-myrtenol, 
camphene, β-elemene, and α-humulene are predominant 
in the first hour fraction.
4. Conclusion
The results from this study show that several constitu-
ents of the essential oils have potentials as medicaments 
in the management of hypertension, nervous disorders, 
headache, pain, and leprosy. Insecticidal potential is also 
proposed. Some of the constituents, such as phytol, (13S)-
8,13-epoxy-labd-14-ene, n-hexadecanoic acid, 1,13-tri-
decanediol diacetate, α-gurjunene, and germacrene D can 
be isolated from the essential oils and their bioactivities 
investigated. The effects of climate, soil, drying conditions, 
and methods of isolation of the essential oils on the constit-
uents should also be investigated. 
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SAŽETAK
Potencijal sastojaka esencijalnog ulja iz lišća biljke  
Adenia cissampeloides za primjenu u medicini i kao pesticida
Modupe Ogunlesi,* Wesley Okiei, Edith Ofor i Anthony Eniola
Adenia cissampeloides (Panch. ex. Hook.) Harms je biljka koja se u alternativnoj medicini pri-
marno upotrebljava za ublažavanje hipertenzije i nekoliko drugih bolesti. Provedena je izolacija i 
GC-MS analiza pet esencijalnih ulja frakcijski izdvojenih za vrijeme hidrodestilacije osušenog lišća 
koja je trajala preko četiri sata. Ulja su sadržavala fitol, α-linolensku kiselinu, n-heksadekanoičnu 
kiselinu, heksahidrofarnezil aceton, (13S)-8,13-epoksi-labd-14-en, kaur-16-en, gvajol, α-gurjunen 
i α-elemen. Provedena je rasprava i o nekoliko različitih bioaktivnosti sastojaka kao i o njihovoj 
potencijalnoj primjeni u medicini, farmaciji i industriji pesticida. Sastojci izolirani iz A. cissampe-
loides postoje i u esencijalnim uljima nekih drugih biljaka. Bioaktivnosti takvih biljaka upućuju na 
to da postoje i druge moguće primjene A. cissampeloides.
Ključne riječi 
Adenia cissampeloides, GC-MS, ljekovito bilje, esencijalna ulja, bioaktivnost
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